Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma

被引：5
|
作者：
Kong, Weihao [1 ]
Li, Xutong [2 ]
Xu, Honghai [3 ]
Gao, Yufeng [2 ]
机构：
[1] Anhui Med Univ, Dept Emergency Surg, Dept Emergency Med, Affiliated Hosp 1, Hefei 230022, Peoples R China
[2] Anhui Med Univ, Dept Infect Dis, Affiliated Hosp 1, Hefei 230022, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Pathol, Hefei 230022, Peoples R China
来源：
BIOMARKERS IN MEDICINE | 2020年 / 14卷 / 13期
关键词：
liver cancer; m(6)A RNA methylation; prognosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER;
D O I：
10.2217/bmm-2020-0178
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Background:This study aimed to investigate the prognostic role of m(6)A methylation regulators in hepatocellular carcinoma (HCC).Materials & methods:Gene expression matrices were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium, and Gene Expression Omnibus databases. Univariate and multivariate regression analysis were utilized to determine the m(6)A risk genes.Results:Two m(6)A-related risk genes (YTHDF1, YTHDF2) were identified in the TCGA HCC cohort. The m(6)A-correlated risk score is an independent risk factor for the overall survival of the TCGA HCC cohort. Finally, we verified the reliability of our results using three external datasets.Conclusion:The m(6)A-correlated gene signature has prognostic value in HCC patients and thus provides guidance for the treatment of HCC.
引用
收藏
页码：1217 / 1228
页数：12
相关论文
共 50 条
  • [21] Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
    Wei Tan
    Shiyi Liu
    Zhimin Deng
    Fangfang Dai
    Mengqin Yuan
    Wei Hu
    Bingshu Li
    Yanxiang Cheng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 593 - 608
  • [22] Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
    Tan, Wei
    Liu, Shiyi
    Deng, Zhimin
    Dai, Fangfang
    Yuan, Mengqin
    Hu, Wei
    Li, Bingshu
    Cheng, Yanxiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 593 - 608
  • [23] Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma
    Zhang, Bo-Han
    Yang, Jian
    Jiang, Li
    Lyu, Tao
    Kong, Ling-Xiang
    Tan, Yi-Fei
    Li, Bo
    Zhu, Yun-Feng
    Xi, Ao-Yao
    Xu, Xi
    Yan, Lyu-Nan
    Yang, Jia-Yin
    GENOMICS, 2020, 112 (04) : 2763 - 2771
  • [24] Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma
    Wang, Yi
    Li, Na
    Tian, Di
    Zhou, Chang-Wu
    Wang, You-Hua
    Yang, Chun
    Zeng, Meng-Su
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6451 - 6471
  • [25] An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment
    Du, Yingxi
    Ma, Yarui
    Zhu, Qing
    Liu, Tongzheng
    Jiao, Yuchen
    Yuan, Peng
    Wang, Xiaobing
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [26] Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma
    Peng, Yue-Ling
    Dong, Ya-Fang
    Guo, Li-Li
    Li, Mu-Ye
    Liao, Hui
    Li, Rong-Shan
    PLOS ONE, 2023, 18 (08):
  • [27] Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
    Junjie Kong
    Guangsheng Yu
    Wei Si
    Guangbing Li
    Jiawei Chai
    Yong Liu
    Jun Liu
    BMC Cancer, 22
  • [28] An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
    Zhang, Feng
    Cai, Jialiang
    Hu, Keshu
    Liu, Wenfeng
    Lu, Shenxin
    Tang, Bei
    Li, Miao
    Wu, Weizhong
    Ren, Zhenggang
    Yin, Xin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (13) : 2203 - 2216
  • [29] A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
    Fu, Xing
    Yang, Yuling
    Zhang, Xiaozhi
    FRONTIERS IN GENETICS, 2022, 13
  • [30] Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
    Huang, Changjing
    Zhang, Chenyue
    Sheng, Jie
    Wang, Dan
    Zhao, Yingke
    Qian, Ling
    Xie, Lin
    Meng, Zhiqiang
    FRONTIERS IN GENETICS, 2021, 12
12345